FDA Archives - tgiHealthCareerp

Health News

FDA plans to authorize Pfizer boosters for all adults before week's end: reports

11/17/2021 authorize, FDA, Pfizer, Plans, to

Fox News Flash top headlines for November 17 Fox News Flash top headlines are here. Check out what’s clicking on

Health News

FDA authorizes sample pooling for SalivaDirect PCR COVID-19 test

11/02/2021 authorizes, FDA, pooling, sample

The U.S. Food and Drug Administration (FDA) has authorized the SalivaDirect PCR COVID-19 test created by the Yale School of

Health News

FDA wants less salt in every day American food

10/19/2021 Beverages (, FDA, Food, SODIUM, US

(Reuters) – The U.S. Food and Drug Administration on Wednesday is pushing to cut salt levels by 12% in food

Health News

Moderna wraps full FDA approval request of COVID-19 vaccine

08/25/2021 approva, FDA, Full, Moderna, Wraps

Vaccine investigator on Pfizer receiving FDA approval: ‘Without a doubt’ safe and effective Dr. Reynold Panettieri discusses Pfizer’s FDA approval

Medications

FDA Approves Keytruda (pembrolizumab) Plus Lenvima (lenvatinib) Combination for Patients With Certain Types of Advanced Endometrial Carcinoma

07/26/2021 (pembrol, Approves, FDA, Keytruda

KENILWORTH & WOODCLIFF, N.J.–(BUSINESS WIRE) July 22, 2021 — Merck (NYSE: MRK), known as MSD outside the United States and

Medications

FDA Approves Rezurock

07/22/2021 Approves, FDA, Rezurock

FDA Approves Rezurock (belumosudil) for the Treatment of Patients with Chronic Graft-Versus-Host Disease (cGVHD) NEW YORK, NY / ACCESSWIRE /

Medications

FDA Approves Rylaze

07/02/2021 Approves, FDA, Rylaze

FDA Approves Rylaze for the Treatment of Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma DUBLIN, June 30, 2021 /PRNewswire/ — Jazz

Health News

FDA approval of Biogen's Alzheimer's drug leaves some 'disappointed'

06/08/2021 Approval, Biogen's, FDA, of

Fox News Flash top headlines for June 8 Fox News Flash top headlines are here. Check out what’s clicking on

Medications

FDA Approves Merck’s Keytruda (pembrolizumab) Combined With Trastuzumab and Chemotherapy as First-line Treatment in Locally Advanced Unresectable or Metastatic HER2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma

05/11/2021 Approves, FDA, Keytruda, Merck’s

KENILWORTH, N.J.–(BUSINESS WIRE) May 5, 2021– Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced

Medications

FDA Approves Opdivo (nivolumab) in Combination with Chemotherapy for Patients with Advanced or Metastatic Gastric Cancer, Gastroesophageal Junction Cancer, and Esophageal Adenocarcinoma Regardless of PD-L1 Expression Status

04/18/2021 (nivolumab), Adenocarcinoma, advanced, and, Approves, cancer, chemotherapy, Combination, Esophageal, expression, FDA, for, gastric, gastroesophageal, in, Junction, metastatic, of, Opdivo, or, Patients, PD-L1, regardless, status, with

PRINCETON, N.J.–(BUSINESS WIRE)– April 16, 2021 Opdivo is the first and only immunotherapy in combination with chemotherapy to deliver superior overall

← Previous